Company / R&D per Share
Caribou Biosciences, Inc. R&D per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.18
FY2025
5-year range
$0.87 / $2.43
FY2021-FY2025
Trend
-6.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $1.35 to $1.18 over the past 2 years.
Based on SEC 10-K filings.
1.18 in FY2025 with a 3-year CAGR of +11.0%.
Declined from $1.35 to $1.18 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +11.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 6.5% year-over-year.
- Peak r&d per share was recorded in FY2021.
- Lowest r&d per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.18 | -6.5% |
| FY2024 | $1.27 | -6.0% |
| FY2023 | $1.35 | +55.4% |
| FY2022 | $0.87 | -64.4% |
| FY2021 | $2.43 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026